Rowe IA - Search Results

1

A comparative quality assessment of evidence-based clinical guidelines in endocrinology.

Hazlehurst JM, Armstrong MJ, Sherlock M, Rowe IA, O'Reilly MW, Franklyn JA, Stewart PM, Tomlinson JW. Hazlehurst JM, et al. Among authors: rowe ia. Clin Endocrinol (Oxf). 2013 Feb;78(2):183-90. doi: 10.1111/j.1365-2265.2012.04441.x. Clin Endocrinol (Oxf). 2013. PMID: 22624723

2

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.

Armstrong MJ, Houlihan DD, Rowe IA. Armstrong MJ, et al. Among authors: rowe ia. N Engl J Med. 2010 Sep 16;363(12):1185; author reply 1186. doi: 10.1056/NEJMc1006581. N Engl J Med. 2010. PMID: 20843257 Free article. No abstract available.

3

Renal function in patients undergoing transplantation for nonalcoholic steatohepatitis cirrhosis: time to reconsider immunosuppression regimens?

Houlihan DD, Armstrong MJ, Davidov Y, Hodson J, Nightingale P, Rowe IA, Paris S, Gunson BK, Bramhall SB, Mutimer DJ, Neuberger JM, Newsome PN. Houlihan DD, et al. Among authors: rowe ia. Liver Transpl. 2011 Nov;17(11):1292-8. doi: 10.1002/lt.22382. Liver Transpl. 2011. PMID: 21761549 Free article.

4

Prioritizing treatment experienced patients with hepatitis C infection for treatment with telaprevir: a number needed to treat approach.

Rowe IA, Armstrong MJ, Houlihan DD. Rowe IA, et al. Hepatology. 2012 May;55(5):1644-5. doi: 10.1002/hep.25553. Hepatology. 2012. PMID: 22212958 No abstract available.

5

Informed consent in surveillance for hepatocellular carcinoma in patients with cirrhosis.

Rowe IA, Armstrong MJ, Parker R, Houlihan DD. Rowe IA, et al. Hepatology. 2012 Jun;55(6):2039; author reply 2039-40. doi: 10.1002/hep.25588. Hepatology. 2012. PMID: 22262284 No abstract available.

6

Hepatitis A virus vaccination in persons with hepatitis C virus infection: consequences of quality measure implementation.

Rowe IA, Parker R, Armstrong MJ, Houlihan DD, Mutimer DJ. Rowe IA, et al. Hepatology. 2012 Aug;56(2):501-6. doi: 10.1002/hep.25683. Epub 2012 Jun 11. Hepatology. 2012. PMID: 22371026

7

Assessment of the quality of evidence underlying international guidelines in liver disease.

Rowe IA, Parker R, Armstrong MJ, King AL, Houlihan DD, Mutimer D. Rowe IA, et al. Am J Gastroenterol. 2012 Sep;107(9):1276-82. doi: 10.1038/ajg.2012.71. Am J Gastroenterol. 2012. PMID: 22951868

8

HTLV-1 in solid-organ transplantation: current challenges and future management strategies.

Armstrong MJ, Corbett C, Rowe IA, Taylor GP, Neuberger JM. Armstrong MJ, et al. Among authors: rowe ia. Transplantation. 2012 Dec 15;94(11):1075-84. doi: 10.1097/TP.0b013e318263ad7a. Transplantation. 2012. PMID: 23060278 Review.

9

Improving the quality of clinical practice guidelines for clinicians and patients.

Rowe IA, Parker R, Armstrong MJ, King AL, Houlihan DD, Mutimer DJ. Rowe IA, et al. Hepatology. 2014 May;59(5):2055-6. doi: 10.1002/hep.26756. Epub 2014 Mar 27. Hepatology. 2014. PMID: 24123187 No abstract available.

10

Effect of scavenger receptor class B type I antagonist ITX5061 in patients with hepatitis C virus infection undergoing liver transplantation.

Rowe IA, Tully DC, Armstrong MJ, Parker R, Guo K, Barton D, Morse GD, Venuto CS, Ogilvie CB, Hedegaard DL, McKelvy JF, Wong-Staal F, Allen TM, Balfe P, McKeating JA, Mutimer DJ. Rowe IA, et al. Liver Transpl. 2016 Mar;22(3):287-97. doi: 10.1002/lt.24349. Liver Transpl. 2016. PMID: 26437376 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117 results

Search Page

Filters